Country: United States
Language: English
Source: NLM (National Library of Medicine)
FLUNIXIN MEGLUMINE (UNII: 8Y3JK0JW3U) (FLUNIXIN - UNII:356IB1O400), phenol (UNII: 339NCG44TV) (PHENOL - UNII:339NCG44TV)
Huvepharma, Inc
INTRAVENOUS
PRESCRIPTION
Only for Intravenous Use in Beef and Dairy Cattle. Not for Use in Dry Dairy Cows and Veal Calves. For Intravenous and Intramuscular use in Horses. Before using this drug, read package outsert for complete product information. Only for Intravenous Use in Beef and Dairy Cattle. Not for Use in Dry Dairy Cows and Veal Calves. For Intravenous and Intramuscular Use in Horses. Indications Horse: Flu-Nix™ (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. It is also recommended for the alleviation of visceral pain associated with colic in the horse. Cattle: Flu-Nix™ (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. Flu-Nix™ (flunixin meglumine injection) is also indicated for the control of inflammation in endotoxemia. Contraindications Horse: There are no known contraindications t
How Supplied Flu-Nix™ (flunixin meglumine injection), 50 mg/mL, is available in 100 mL and 250 mL multi-dose vials. How Supplied Flu-Nix™ (flunixin meglumine injection), 50 mg/mL, is available in 100 mL and 250 mL multi-dose vials.
Abbreviated New Animal Drug Application
FLU-NIX- FLUNIXIN MEGLUMINE INJECTION, SOLUTION HUVEPHARMA, INC ---------- STERILE NDC 23243-0120-4 FLU-NIX™ (FLUNIXIN MEGLUMINE INJECTION) 50 MG/ML CAUTION: FEDERAL LAW RESTRICTS THIS DRUG TO USE BY OR ON THE ORDER OF A LICENSED VETERINARIAN. APPROVED BY FDA UNDER ANADA # 200-061 NET CONTENTS: 100 ML Only for Intravenous Use in Beef and Dairy Cattle. Not for Use in Dry Dairy Cows and Veal Calves. For Intravenous and Intramuscular use in Horses. Before using this drug, read package outsert for complete product information. To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Huvepharma, Inc. at 1-877-994-4883 or www.huvepharma.us. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae. ®Registered trademark of Huvepharma, Inc. Manufactured for Huvepharma, Inc. Rev. 09-2021 Peachtree City, GA 30269 F-2847-04 RESIDUE WARNINGS: Cattle must not be slaughtered for human consumption within 4 days of the last treatment. Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. Not for use in dry dairy cows. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Do not use in horses intended for food. Approved only for intravenous administration in cattle. Intramuscular administration has resulted in violative residues in the edible tissues of cattle sent to slaughter. STORE AT CONTROLLED ROOM TEMPERATURE, 20º TO 25º C (68º TO 77º F) [SEE USP]. Lot No.: Exp. Date: FLU-NIX™ (FLUNIXIN MEGLUMINE INJECTION) 50 MG/ML ONLY FOR INTRAVENOUS USE IN BEEF AND DAIRY CATTLE. NOT FOR USE IN DRY DAIRY COWS AND VEAL CALVES. FOR INTRAVENOUS AND INTRAMUSCULAR USE IN HORSES. CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION Each milliliter of Flu-Nix™ (flunixin meglumine inject Read the complete document